Domine Gomez, Manuel manuel.domine@uam.es
Actividades
- Artículos 38
- Libros 1
- Capítulos de libro 0
- Congresos 0
- Documentos de trabajo 0
- Informes técnicos 0
- Proyectos de investigación 0
- Tesis dirigidas 0
- Patentes o licencias de software 0
First-line Atezolizumab plus Bevacizumab for Metastatic High-Intermediate TMB in Non-squamous NSCLC. The TELMA Study
- Provencio-pulla, M
- Ortega, AL
- Coves, J
- Franco, F
- Marse, R
- Domine, M
- Guirado, M
- Carcereny, E
- Fernandez, N
- Martinez, E
- Blanco, R
- Leon, L
- Sanchez, JM
- Sullivan, I
- Cobo, M
- Sanchez, A
- Massuti, B
Journal Of Thoracic Oncology (p. S123-S124) - 1/9/2022
- ISSN 15560864
- iMarina
Multidisciplinary Thoracic Tumors Board Survey in Spain
- Massuti, B
- Nadal, E
- Camps, C
- Carcereny, E
- Cobo, M
- Domine, M
- Garcia-Campelo, MR
- Gonzalez-Larriba, JL
- Guirado, M
- Hernando-Trancho, F
- Rodriguez-Abreu, D
- Sanchez, A
- Sullivan, I
- Provencio, M
Journal Of Thoracic Oncology (p. S107-S107) - 1/9/2022
- ISSN 15560864
- iMarina
NIVIPI-BRAIN, A Phase II Study of Nivolumab plus Ipilimumab Combined with Chemotherapy for Patients with NSCLC and Synchronous Brain Metastases
- Nadal, E
- Cantero, A
- Ortega, AL
- Domine, M
- Barba, A
- Blasco, A
- Garcia, J
- Mosquera, J
- Vazquez, S
- Rodriguez, D
- Lopez-Castro, R
- Juan Vidal, O
- Sanchez, A
- Paz Ares, L
- Hernandez, A
- Iranzo, P
- Diz, P
- Provencio, M
- Simo, M
- Navarro, V
- Bruna, J
Journal Of Thoracic Oncology (p. S350-S351) - 1/9/2022
- ISSN 15560864
- iMarina
RET Fusion Testing with FISH and Real-Time PCR: a Comparison with RNA-Based Next-Generation Sequencing in RET Positive NSCLC
- Hernandez, S
- Carrillo, JLR
- Caminoa, A
- Benito, A
- Martinez, R
- Alonso, M
- Clave, S
- Arriola, E
- Esteban-Rodriguez, I
- De Castro, J
- Sansano, I
- Felip, E
- Abdulkader, I
- Garcia, J
- Rojo, F
- Domine, M
- Teixido, C
- Reguart, N
- Compan, D
- Insa, A
- Mancheno, N
- Palanca, S
- Juan, O
- Baixeras, N
- Nadal, E
- Cebollero, M
- Calles, A
- Martin, P
- Salas, C
- Provencio, M
- Aranda, I
- Massuti, B
- Lopez-Vilaro, L
- Majem, M
- Garrido, P
- Paz-Ares, L
- Lopez-Rios, F
- Conde, E
Journal Of Thoracic Oncology (p. S135-S136) - 1/9/2022
- ISSN 15560864
- iMarina
Postoperative Chemotherapy Use and Outcomes From ADAURA: Osimertinib as Adjuvant Therapy for Resected EGFR-Mutated NSCLC
- Wu, YL
- John, T
- Grohe, C
- Majem, M
- Goldman, JW
- Kim, SW
- Kato, T
- Laktionov, K
- Vu, HV
- Wang, ZJ
- Lu, S
- Lee, KY
- Akewanlop, C
- Yu, CJ
- de Marinis, F
- Bonanno, L
- Domine, M
- Shepherd, FA
- Zeng, LM
- Atasoy, A
- Herbst, RS
- Tsuboi, M
Journal Of Thoracic Oncology (p. 423-433) - 1/3/2022
10.1016/j.jtho.2021.10.014 Ver en origen
- ISSN 15560864
Overall Survival and Biomarker Analysis of Neoadjuvant Nivolumab Plus Chemotherapy in Operable Stage IIIA Non-Small-Cell Lung Cancer (NADIM phase II trial)
- Provencio M
- Serna-Blasco R
- Nadal E
- Insa A
- García-Campelo MR
- Casal Rubio J
- Dómine M
- Majem M
- Rodríguez-Abreu D
- Martínez-Martí A
- De Castro Carpeño J
- Cobo M
- López Vivanco G
- Del Barco E
- Bernabé Caro R
- Viñolas N
- Barneto Aranda I
- Viteri S
- Pereira E
- Royuela A
- Calvo V
- Martín-López J
- García-García F
- Casarrubios M
- Franco F
- Sánchez-Herrero E
- Massuti B
- Cruz-Bermúdez A
- Romero A
Journal Of Clinical Oncology (p. 2924-2933) - 1/5/2022
10.1200/jco.21.02660 Ver en origen
- ISSN 0732183X
Multimodal prediction of response to neoadjuvant nivolumab and chemotherapy for surgically resectable stage IIIA non-small cell lung cancer.
- Ferrer, L
- Nadal, E
- Guidel, F
- Insa, A
- Menu, P
- Casal, J
- Domine, M
- Massuti, B
- Majem, M
- Martinez-Marti, A
- Campelo, RG
- Carpeon, JD
- Cobo, M
- Vivanco, GL
- del Barco, E
- Bernabe, R
- Vinolas, N
- Barneto, I
- Colin, T
- Provencio-Pulla, M
Journal Of Clinical Oncology - 1/6/2022
- ISSN 0732183X
- iMarina
Adjuvant Osimertinib for Resected EGFR-Mutated Stage IB-IIIA Non Small-Cell Lung Cancer: Updated Results From the Phase III Randomized ADAURA Trial
- Herbst RS
- Wu YL
- John T
- Grohe C
- Majem M
- Wang J
- Kato T
- Goldman JW
- Laktionov K
- Kim SW
- Yu CJ
- Vu HV
- Lu S
- Lee KY
- Mukhametshina G
- Akewanlop C
- De Marinis F
- Bonanno L
- Domine M
- Shepherd FA
- Urban D
- Huang X
- Bolanos A
- Stachowiak M
- Tsuboi M
Journal Of Clinical Oncology (p. 1830-1840) - 1/4/2023
10.1200/jco.22.02186 Ver en origen
- ISSN 0732183X
Tumor microenvironment gene expression profiles associated to complete pathological response and disease progression in resectable NSCLC patients treated with neoadjuvant chemoimmunotherapy
- Casarrubios, Marta
- Provencio, Mariano
- Nadal, Ernest
- Insa, Amelia
- Garcia-Campelo, Maria Del Rosario
- Lazaro-Quintela, Martin
- Domine, Manuel
- Majem, Margarita
- Rodriguez-Abreu, Delvys
- Martinez-Marti, Alex
- Carpeno, Javier De Castro
- Cobo, Manuel
- Vivanco, Guillermo Lopez
- Del Barco, Edel
- Bernabe, Reyes
- Vinolas, Nuria
- Aranda, Isidoro Barneto
- Massuti, Bartomeu
- Sierra-Rodero, Belen
- Martinez-Toledo, Cristina
- Fernandez-Miranda, Ismael
- Serna-Blanco, Roberto
- Romero, Atocha
- Calvo, Virginia
- Cruz-Bermudez, Alberto;
Journal For Immunotherapy Of Cancer - 28/9/2022
10.1136/jitc-2022-005320 Ver en origen
- ISSN 20511426
Atezolizumab Plus Bevacizumab as First-line Treatment for Patients with Metastatic Nonsquamous Non-Small Cell Lung Cancer with High Tumor Mutation Burden: A Nonrandomized Controlled Trial
- Provencio M
- Ortega AL
- Coves-Sarto J
- Calvo V
- Marsé-Fabregat R
- Dómine M
- Guirado M
- Carcereny E
- Fernández N
- Álvarez R
- Blanco R
- León-Mateos L
- Sánchez-Torres JM
- Sullivan IG
- Cobo M
- Sánchez-Hernández A
- Massuti B
- Sierra-Rodero B
- Mártinez-Toledo C
- Serna-Blasco R
- Romero A
- Cruz-Bermúdez A
Jama Oncology (p. 344-353) - 16/3/2023
10.1001/jamaoncol.2022.5959 Ver en origen
- ISSN 23742445
Este/a investigador/a no tiene capítulos de libro.
Este/a investigador/a no tiene congresos.
Este/a investigador/a no tiene documentos de trabajo.
Este/a investigador/a no tiene informes técnicos.
Este/a investigador/a no tiene proyectos de investigación.
Este/a investigador/a no tiene tesis dirigidas.
Este/a investigador/a no tiene patentes o licencias de software.
Perfiles de investigador/a
-
ORCID
-
Scopus Author ID
-
Dialnet id